Your browser doesn't support javascript.
loading
Predicting master transcription factors from pan-cancer expression data.
Reddy, Jessica; Fonseca, Marcos A S; Corona, Rosario I; Nameki, Robbin; Segato Dezem, Felipe; Klein, Isaac A; Chang, Heidi; Chaves-Moreira, Daniele; Afeyan, Lena K; Malta, Tathiane M; Lin, Xianzhi; Abbasi, Forough; Font-Tello, Alba; Sabedot, Thais; Cejas, Paloma; Rodríguez-Malavé, Norma; Seo, Ji-Heui; Lin, De-Chen; Matulonis, Ursula; Karlan, Beth Y; Gayther, Simon A; Pasaniuc, Bogdan; Gusev, Alexander; Noushmehr, Houtan; Long, Henry; Freedman, Matthew L; Drapkin, Ronny; Young, Richard A; Abraham, Brian J; Lawrenson, Kate.
Afiliação
  • Reddy J; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Fonseca MAS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Corona RI; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Nameki R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Segato Dezem F; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Klein IA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Chang H; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Chaves-Moreira D; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Afeyan LK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Malta TM; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Lin X; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Abbasi F; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Font-Tello A; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Sabedot T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cejas P; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Rodríguez-Malavé N; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Seo JH; Penn Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Lin DC; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Matulonis U; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Karlan BY; Henry Ford Hospital, Detroit, MI, USA.
  • Gayther SA; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Pasaniuc B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Gusev A; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Noushmehr H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Long H; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Freedman ML; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Drapkin R; Henry Ford Hospital, Detroit, MI, USA.
  • Young RA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Abraham BJ; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Lawrenson K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Sci Adv ; 7(48): eabf6123, 2021 Nov 26.
Article em En | MEDLINE | ID: mdl-34818047
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos